The Trump administration’s recent efforts to increase transparency in hospital pricing have expectedly been met with legal push-back from the hospitals themselves. But shadowy hospital pricing is just the tip of the opaque iceberg that is driving up the costs of health care in America. To inject more competition into the industry, Congress and the White House needs to shed light on the pharmacy benefit manager (PBM) middlemen who keep prescription drug prices high.

To learn more, read our article published in Real Clear Health.